PNC Financial Services Group
ARIA

PNC Financial Services Group’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

PNC Financial Services Group’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-15,640
Closed -$194K – 4322
2016
Q4 		$194K Sell
15,640
-4,580
-23% -$55.2K ﹤0.01% 2124
2016
Q3 		$277K Sell
20,220
-13,567
-40% -$136K ﹤0.01% 1898
2016
Q2 		$249K Sell
33,787
-9,679
-22% -$72.6K ﹤0.01% 1947
2016
Q1 		$279K Buy
43,466
+3,756
+9% +$21.1K ﹤0.01% 1891
2015
Q4 		$249K Buy
39,710
+5,520
+16% +$36.2K ﹤0.01% 1941
2015
Q3 		$199K Buy
34,190
+313
+0.9% +$2.41K ﹤0.01% 2119
2015
Q2 		$281K Buy
33,877
+2,972
+10% +$26.3K ﹤0.01% 2000
2015
Q1 		$254K Buy
30,905
+1,948
+7% +$14.4K ﹤0.01% 2062
2014
Q4 		$199K Buy
28,957
+23,353
+417% +$146K ﹤0.01% 2070
2014
Q3 		$30K Hold
5,604
– – ﹤0.01% 2907
2014
Q2 		$36K Hold
5,604
– – ﹤0.01% 2721
2014
Q1 		$45K Sell
5,604
-145
-3% -$1.13K ﹤0.01% 2548
2013
Q4 		$39K Sell
5,749
-1,636
-22% -$8.83K ﹤0.01% 2589
2013
Q3 		$135K Buy
7,385
+3,959
+116% +$76.9K ﹤0.01% 2032
2013
Q2 		$60K Buy
+3,426
New +$60.7K ﹤0.01% 2316

Other funds holding ARIA

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

PNC Financial Services Group's ARIA Position: Q1 2017 in Review

PNC Financial Services Group sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 15,640 shares — an estimated $194K sold.

PNC Financial Services Group first reported a position in ARIA in Q2 2013 and held it in 15 quarters. The position peaked at $281K in Q2 2015. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

  • PNC Financial Services Group reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • PNC Financial Services Group sold 15,640 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $194K.
  • PNC Financial Services Group first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 15 quarters.
  • PNC Financial Services Group's Ariad Pharmaceuticals Inc position peaked at $281K in Q2 2015.
  • 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on PNC Financial Services Group's 13F filing for Q1 2017, filed 12 May 2017.